These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37838776)

  • 1. Abl depletion via autophagy mediates the beneficial effects of quercetin against Alzheimer pathology across species.
    Schiavi A; Cirotti C; Gerber LS; Di Lauro G; Maglioni S; Shibao PYT; Montresor S; Kirstein J; Petzsch P; Köhrer K; Schins RPF; Wahle T; Barilà D; Ventura N
    Cell Death Discov; 2023 Oct; 9(1):376. PubMed ID: 37838776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative effect of Luffa cylindrica fruits on Caenorhabditis elegans and cellular models of Alzheimer's disease-related pathology via autophagy induction.
    Long T; Chen X; Qin DL; Zhu YF; Zhou YJ; He YN; Fu HJ; Tang Y; Yu L; Huang FH; Wang L; Yu CL; Law BY; Wu JM; Wu AG; Zhou XG
    Phytother Res; 2023 Oct; 37(10):4639-4654. PubMed ID: 37394882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of Radix Stellariae extract against Alzheimer's disease via autophagy activation in Caenorhabditis elegans and cellular models.
    Long T; Chen X; Zhang Y; Zhou YJ; He YN; Zhu YF; Fu HJ; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
    Biomed Pharmacother; 2023 Sep; 165():115261. PubMed ID: 37549461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease.
    Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L
    J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
    Regitz C; Dußling LM; Wenzel U
    Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Li J; Cui X; Ma X; Wang Z
    Exp Gerontol; 2017 Mar; 89():78-86. PubMed ID: 28119052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
    Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting autophagy to discover the Piper wallichii petroleum ether fraction exhibiting antiaging and anti-Alzheimer's disease effects in Caenorhabditis elegans.
    Zhu FD; Chen X; Yu L; Hu ML; Pan YR; Qin DL; Wu JM; Li L; Law BY; Wong VK; Zhou XG; Wu AG; Fan DS
    Phytomedicine; 2023 Aug; 117():154916. PubMed ID: 37327643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hesperidin ameliorates Amyloid-β toxicity and enhances oxidative stress resistance and lifespan of Caenorhabditis elegans through acr-16 mediated activation of the autophagy pathway.
    Kumar S; Akhila PV; Suchiang K
    Free Radic Biol Med; 2023 Nov; 209(Pt 2):366-380. PubMed ID: 37913913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-butanol extract of Hedyotis diffusa protects transgenic Caenorhabditis elegans from Aβ-induced toxicity.
    DanQing L; YuJie G; ChengPeng Z; HongZhi D; Yi H; BiSheng H; Yan C
    Phytother Res; 2021 Feb; 35(2):1048-1061. PubMed ID: 32924204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of the traditional decoction Tian-Si-Yin against Alzheimer's disease via suppression of neuroinflammation.
    Zhou L; Yang C; Liu Z; Chen L; Wang P; Zhou Y; Yuan M; Zhou LT; Wang X; Zhu LQ
    J Ethnopharmacol; 2024 Mar; 321():117569. PubMed ID: 38086513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine prevents in vivo Aβ toxicity in Caenorhabditis elegans via SKN-1.
    Lu X; Zhang Y; Li H; Jin Y; Zhao L; Wang X
    Neurosci Lett; 2021 Sep; 761():136114. PubMed ID: 34274434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.
    Wang X; Yi K; Zhao Y
    Food Funct; 2018 Jan; 9(1):552-560. PubMed ID: 29260173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black mulberry (Morus nigra) fruit extract alleviated AD-Like symptoms induced by toxic Aβ protein in transgenic Caenorhabditis elegans via insulin DAF-16 signaling pathway.
    Wang E; Wang N; Zou Y; Fahim M; Zhou Y; Yang H; Liu Y; Li H
    Food Res Int; 2022 Oct; 160():111696. PubMed ID: 36076399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-life and chronic exposure to di(2-ethylhexyl) phthalate enhances amyloid-β toxicity associated with an autophagy-related gene in Caenorhabditis elegans Alzheimer's disease models.
    Yen PL; How CM; Hsiu-Chuan Liao V
    Chemosphere; 2021 Jun; 273():128594. PubMed ID: 33066971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deer antler extracts reduce amyloid-beta toxicity in a Caenorhabditis elegans model of Alzheimer's disease.
    Du F; Zhao H; Yao M; Yang Y; Jiao J; Li C
    J Ethnopharmacol; 2022 Mar; 285():114850. PubMed ID: 34801608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.
    Alexander AG; Marfil V; Li C
    Front Genet; 2014; 5():279. PubMed ID: 25250042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.